Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · Real-Time Price · USD
2.685
+0.005 (0.19%)
At close: Sep 12, 2025, 4:00 PM EDT
2.690
+0.005 (0.19%)
After-hours: Sep 12, 2025, 4:00 PM EDT
Quipt Home Medical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Quipt Home Medical stock have a consensus rating of "Buy" and an average price target of $3.15, which forecasts a 17.32% increase in the stock price over the next year. The lowest target is $2.30 and the highest is $4.00.
Price Target: $3.15 (+17.32%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quipt Home Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.7 → $2.3 | Hold | Maintains | $1.7 → $2.3 | -14.34% | Aug 19, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $6 → $4 | Strong Buy | Maintains | $6 → $4 | +48.98% | May 14, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $4 → $1.7 | Strong Buy → Hold | Downgrades | $4 → $1.7 | -36.69% | May 13, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +160.71% | Aug 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +123.46% | Aug 16, 2024 |
Financial Forecast
Revenue This Year
245.41M
from 245.92M
Decreased by -0.21%
Revenue Next Year
313.13M
from 245.41M
Increased by 27.59%
EPS This Year
-0.18
from -0.16
EPS Next Year
-0.21
from -0.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 259.4M | 324.3M | |
| Avg | 245.4M | 313.1M | |
| Low | 232.6M | 299.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.5% | 32.1% | |
| Avg | -0.2% | 27.6% | |
| Low | -5.4% | 21.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.14 | -0.22 | |
| Avg | -0.18 | -0.21 | |
| Low | -0.23 | -0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.